Skip to content
OpenCapital
Get started

Olema Pharmaceuticals, Inc. OLMA Q2 2025 earnings

Reported August 11, 2025 · Before market open

Diluted EPS-$0.51Miss by $0.08
EPS estimate-$0.43

Next report

Aug 10, 2026 (In 4 weeks)
EPS estimate-$0.53

Financials

Q2 2025

Income statement

See full
Operating income-$47.9M-42.7%
Net income-$43.8M-44.1%
EPS (diluted)-$0.51+5.6%

Balance sheet

See full
Cash & equivalents$52.5M+211%
Total debt$1.8M-10.6%
Total equity$345.2M+52.0%
Total assets$382.0M+50.1%

Cash flow

See full
Operating cash flow-$29.9M-8.4%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$320.9M-46.6%
Enterprise value$270.18M-53.9%

Returns & leverage

See full
Return on equity-49.7%-5.3pp
Debt / equity0×0.0×
Current ratio11.1×+2.0×

Versus estimates

Diluted EPS

Q1 2026-$0.52In lineQ4 2025-$0.50Beat by $0.01Q3 2025-$0.49Miss by $0.05
Q2 2025-$0.51Miss by $0.08
Q1 2025-$0.36Beat by $0.13Q4 2024-$0.51Beat by $0.12

Ask the moment Olema Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Olema Pharmaceuticals, Inc. report Q2 2025 earnings?
Olema Pharmaceuticals, Inc. (OLMA) reported Q2 2025 earnings on August 11, 2025 before market open.
What were Olema Pharmaceuticals, Inc.'s Q2 2025 revenue and EPS?
Olema Pharmaceuticals, Inc. reported diluted EPS of $-0.51 for Q2 2025.
Did Olema Pharmaceuticals, Inc. beat estimates in Q2 2025?
EPS missed the consensus estimate of $-0.43 by $0.08.
How did Olema Pharmaceuticals, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 5.6% from $-0.54.
Where can I find Olema Pharmaceuticals, Inc.'s Q2 2025 SEC filings?
You can read the 10-Q periodic report (0000950170-25-106565) directly on SEC EDGAR. The filing index links above go to sec.gov.